News|Articles|November 6, 2024

Case studies: How top biopharma companies are scaling protocol optimization and streamlining data acquisition

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Leveraging remote-based regional hubs in FSP partnerships
June 26th 2025
Establishing a Bespoke Outsourcing Arrangement with Hybrid FSP/FSO Partnerships
June 26th 2025
2025 FSP Trends Report
June 26th 2025
Focus on biotech: Harnessing FSP engagements to deliver on-time, on-budget
June 19th 2025
FSP Outsourcing in Clinical Research: Trends and Opportunities
June 9th 2025
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025

Trending on Applied Clinical Trials Online

Driving Transformation With a Connected Clinical Platform: 2025 Veeva R&D and Quality Summit Clinical Opening Keynote

AstraZeneca’s Baxdrostat Shows Promise in Phase III Trial for Hard-to-Control Hypertension

Promising Trial Data Leads to Breakthrough Designation for Eli Lilly’s Investigational KRAS G12C Inhibitor in Advanced, Metastatic Non-Small Cell Lung Cancer

Case studies: How top biopharma companies are scaling protocol optimization and streamlining data acquisition

Newsletter

Related Articles

Trending on Applied Clinical Trials Online

Driving Transformation With a Connected Clinical Platform: 2025 Veeva R&D and Quality Summit Clinical Opening Keynote

AstraZeneca’s Baxdrostat Shows Promise in Phase III Trial for Hard-to-Control Hypertension

Promising Trial Data Leads to Breakthrough Designation for Eli Lilly’s Investigational KRAS G12C Inhibitor in Advanced, Metastatic Non-Small Cell Lung Cancer

Merck’s Oral PCSK9 Inhibitor Demonstrates Efficacy in Hypercholesterolemia

Epkinly Demonstrates Encouraging Efficacy in Phase II Trial for Relapsed or Refractory Diffuse Large B-Cell Lymphoma